Preparation and evaluation of novel stationary phases for improved chromatographic purification of Pneumocandin B0 (cas 135575-42-7)

Add time:08/13/2019    Source:sciencedirect.com

Preparation and evaluation of a number of stationary phases for improved chromatographic purification of pneumocandin B0, a key intermediate in the synthesis of the antifungal agent, Cancidas, has led to the identification of several materials with potential for improved performance.

We also recommend Trading Suppliers and Manufacturers of Pneumocandin B0 (cas 135575-42-7). Pls Click Website Link as below: cas 135575-42-7 suppliers

Prev:PIFA–BF3·OEt2 mediated intramolecular regioselective domino cyclization of ynamides: A novel method for the synthesis of tetrahydroisoquinoline-oxazol-2(3H)-ones
Next:Antifungal lipopeptides: Structure-activity relationships of 3-hydroxyglutamine-modified Pneumocandin B0 (cas 135575-42-7) derivatives)